Skip to main content
Log in

Clinical features of subarachnoid hemorrhage in patients with positive cancer history

  • Clinical Study
  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Abstract

Advances in cancer treatment have dramatically increased long-term survivors. Prolonged survival increases comorbidity risk, but there is a paucity of studies on how cancer history alters clinical outcomes from subsequent diseases. This study aims to investigate whether positive cancer history influences clinical outcome following subarachnoid hemorrhage (SAH). We retrospectively reviewed consecutive SAH patients admitted between January 2008 and March 2014. Medical histories, known SAH risk factors, and outcome were compared between SAH patients with and without cancer history. Out of the 498 SAH patients, 55 cases had cancer history, 438 cases had no cancer history and 5 cases had an unknown cancer history. Compared with SAH patients without cancer history, those with cancer history had poorer Hunt & Hess grade at SAH presentation (P = 0.021), and poorer modified Rankin Scale (mRS) score at discharge (P < 0.001). After adjustment for age, sex, modified Fisher, previous SAH, history of hypertension, current smoking status, and current alcohol consumption, positive cancer history remained an independent risk factor for poorer mRS0–6 [odds ratio (OR) = 2.25, 95 % confidence interval (CI) 1.28–3.94] and mRS6 (OR = 2.74, 95 % CI 1.40–5.37). Furthermore, stratified analysis by Hunt & Hess grade adjusted by age, sex, and modified Fisher scale, OR of poorer mRS0–6 was 2.12 (95 % CI 0.89–5.05) and OR of mRS6 was 3.68 (95 % CI 1.35–10.04). After adjustment of patients for demographic factors, classical risk factors for SAH and Hunt & Hess grade, previous cancer history is a risk factor for the poor functional outcome of SAH.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Askoxylakis V, Thieke C, Pleger ST, Most P, Tanner J, Lindel K, Katus HA, Debus J, Bischof M (2010) Long-term survival of cancer patients compared to heart failure and stroke: a systematic review. BMC Cancer 10:105. doi:10.1186/1471-2407-10-105

    Article  PubMed  PubMed Central  Google Scholar 

  2. Grisold W, Oberndorfer S, Struhal W (2009) Stroke and cancer: a review. Acta Neurol Scand 119:1–16. doi:10.1111/j.1600-0404.2008.01059.x

    Article  CAS  PubMed  Google Scholar 

  3. Varki A (2007) Trousseau’s syndrome: multiple definitions and multiple mechanisms. Blood 110:1723–1729. doi:10.1182/blood-2006-10-053736

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Cestari DM, Weine DM, Panageas KS, Segal AZ, DeAngelis LM (2004) Stroke in patients with cancer: incidence and etiology. Neurology 62:2025–2030

    Article  CAS  PubMed  Google Scholar 

  5. Zhang YY, Cordato D, Shen Q, Sheng AZ, Hung WT, Chan DK (2007) Risk factor, pattern, etiology and outcome in ischemic stroke patients with cancer: a nested case–control study. Cerebrovasc Dis 23:181–187. doi:10.1159/000097639

    Article  CAS  PubMed  Google Scholar 

  6. Zhang YY, Chan DK, Cordato D, Shen Q, Sheng AZ (2006) Stroke risk factor, pattern and outcome in patients with cancer. Acta Neurol Scand 114:378–383. doi:10.1111/j.1600-0404.2006.00709.x

    Article  PubMed  Google Scholar 

  7. Rogers LR (2010) Cerebrovascular complications in patients with cancer. Semin Neurol 30:311–319. doi:10.1055/s-0030-1255224

    Article  PubMed  Google Scholar 

  8. Frontera JA, Claassen J, Schmidt JM, Wartenberg KE, Temes R, Connolly ES Jr, MacDonald RL, Mayer SA (2006) Prediction of symptomatic vasospasm after subarachnoid hemorrhage: the modified fisher scale. Neurosurgery 59:21–27; discussion 21–27. doi:10.1227/01.NEU.0000218821.34014.1B

  9. Bath PM, Lees KR, Schellinger PD, Altman H, Bland M, Hogg C, Howard G, Saver JL, European Stroke Organisation Outcomes Working G (2012) Statistical analysis of the primary outcome in acute stroke trials. Stroke 43:1171–1178. doi:10.1161/STROKEAHA.111.641456

  10. Hamdan A, Barnes J, Mitchell P (2014) Subarachnoid hemorrhage and the female sex: analysis of risk factors, aneurysm characteristics, and outcomes. J Neurosurg 121:1367–1373. doi:10.3171/2014.7.JNS132318

    Article  PubMed  Google Scholar 

  11. Rosengart AJ, Schultheiss KE, Tolentino J, Macdonald RL (2007) Prognostic factors for outcome in patients with aneurysmal subarachnoid hemorrhage. Stroke 38:2315–2321. doi:10.1161/STROKEAHA.107.484360

    Article  PubMed  Google Scholar 

  12. Andreasen TH, Bartek J Jr, Andresen M, Springborg JB, Romner B (2013) Modifiable risk factors for aneurysmal subarachnoid hemorrhage. Stroke 44:3607–3612. doi:10.1161/STROKEAHA.113.001575

    Article  PubMed  Google Scholar 

  13. Yamada S, Koizumi A, Iso H, Wada Y, Watanabe Y, Date C, Yamamoto A, Kikuchi S, Inaba Y, Toyoshima H, Kondo T, Tamakoshi A, Japan Collaborative Cohort Study G (2003) Risk factors for fatal subarachnoid hemorrhage: the Japan Collaborative Cohort Study. Stroke 34:2781–2787. doi:10.1161/01.STR.0000103857.13812.9A

  14. Juvela S (2003) Prehemorrhage risk factors for fatal intracranial aneurysm rupture. Stroke 34:1852–1857. doi:10.1161/01.STR.0000080380.56799.DD

    Article  PubMed  Google Scholar 

  15. Lantigua H, Ortega-Gutierrez S, Schmidt JM, Lee K, Badjatia N, Agarwal S, Claassen J, Connolly ES, Mayer SA (2015) Subarachnoid hemorrhage: who dies, and why? Crit Care 19:309. doi:10.1186/s13054-015-1036-0

    Article  PubMed  PubMed Central  Google Scholar 

  16. Mocco J, Ransom ER, Komotar RJ, Schmidt JM, Sciacca RR, Mayer SA, Connolly ES Jr (2006) Preoperative prediction of long-term outcome in poor-grade aneurysmal subarachnoid hemorrhage. Neurosurgery 59:529–538; discussion 529–538. doi:10.1227/01.NEU.0000228680.22550.A2

  17. Pegoli M, Mandrekar J, Rabinstein AA, Lanzino G (2015) Predictors of excellent functional outcome in aneurysmal subarachnoid hemorrhage. J Neurosurg 122:414–418. doi:10.3171/2014.10.JNS14290

    Article  PubMed  Google Scholar 

  18. Pan YX, Chen KF, Lin YX, Wu W, Zhou XM, Zhang XS, Zhang X, Shi JX (2013) Intracisternal administration of SB203580, a p38 mitogen-activated protein kinase inhibitor, attenuates cerebral vasospasm via inhibition of tumor-necrosis factor-alpha. J Clin Neurosci 20:726–730. doi:10.1016/j.jocn.2012.09.012

    Article  CAS  PubMed  Google Scholar 

  19. Hooning MJ, Dorresteijn LD, Aleman BM, Kappelle AC, Klijn JG, Boogerd W, van Leeuwen FE (2006) Decreased risk of stroke among 10-year survivors of breast cancer. J Clin Oncol 24:5388–5394. doi:10.1200/JCO.2006.06.5516

    Article  PubMed  Google Scholar 

  20. Budczies J, von Winterfeld M, Klauschen F, Kimmritz AC, Daniel JM, Warth A, Endris V, Denkert C, Pfeiffer H, Weichert W, Dietel M, Wittschieber D, Stenzinger A (2014) Comprehensive analysis of clinico-pathological data reveals heterogeneous relations between atherosclerosis and cancer. J Clin Pathol 67:482–490. doi:10.1136/jclinpath-2013-202148

    Article  PubMed  Google Scholar 

  21. Navi BB, Reichman JS, Berlin D, Reiner AS, Panageas KS, Segal AZ, DeAngelis LM (2010) Intracerebral and subarachnoid hemorrhage in patients with cancer. Neurology 74:494–501. doi:10.1212/WNL.0b013e3181cef837

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Koppelmans V, Schagen SB, Poels MM, Boogerd W, Seynaeve C, van der Lugt A, Breteler MM (2011) Incidental findings on brain Magnetic Resonance Imaging in long-term survivors of breast cancer treated with adjuvant chemotherapy. Eur J Cancer 47:2531–2536. doi:10.1016/j.ejca.2011.06.026

    Article  PubMed  Google Scholar 

  23. Li F, Downing BD, Smiley LC, Mund JA, Distasi MR, Bessler WK, Sarchet KN, Hinds DM, Kamendulis LM, Hingtgen CM, Case J, Clapp DW, Conway SJ, Stansfield BK, Ingram DA Jr (2014) Neurofibromin-deficient myeloid cells are critical mediators of aneurysm formation in vivo. Circulation 129:1213–1224. doi:10.1161/CIRCULATIONAHA.113.006320

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Rea D, Brandsema JF, Armstrong D, Parkin PC, deVeber G, MacGregor D, Logan WJ, Askalan R (2009) Cerebral arteriopathy in children with neurofibromatosis type 1. Pediatrics 124:e476–e483. doi:10.1542/peds.2009-0152

    Article  PubMed  Google Scholar 

  25. Jeong WK, Park SW, Lee SH, Kim CW (2008) Brachial artery aneurysm rupture in a patient with neurofibromatosis: a case report. J Orthop Surg (Hong Kong) 16:247–250

    CAS  Google Scholar 

Download references

Acknowledgments

We would like to thank Enago (www.enago.jp) for the English language review.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ichiyo Shibahara.

Ethics declarations

Conflict of interest

The authors report no conflict of interest concerning the materials or methods used in this study or the findings specified in this paper.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Shibahara, I., Watanabe, T., Ezura, M. et al. Clinical features of subarachnoid hemorrhage in patients with positive cancer history. J Neurooncol 128, 129–136 (2016). https://doi.org/10.1007/s11060-016-2085-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11060-016-2085-1

Keywords

Navigation